Target Name: LAMP3
NCBI ID: G27074
Review Report on LAMP3 Target / Biomarker Content of Review Report on LAMP3 Target / Biomarker
LAMP3
Other Name(s): lysosomal associated membrane protein 3 | Lysosome-associated membrane glycoprotein 3 | Protein TSC403 | LAMP-3 | Lysosomal-associated membrane protein 3 | LAMP | Lysosomal associated membrane protein 3 | DC LAMP | DC-lysosome-associated membrane glycoprotein | DC-LAMP | DCLAMP | TSC403 | CD208 | LAMP3_HUMAN

Targeting LAMB3 for Brain Health

LAMB3 (Lysosomal Associated Membrane Protein 3) is a protein that is expressed in various cell types, including neurons, glial cells, and blood cells. It is a member of the family of transmembrane proteins, which means that it spans the cell membrane and is involved in various cellular processes.

One of the interesting features of LAMB3 is its role in the regulation of cellular processes that are important for brain development and function. For example, LAMB3 has been shown to play a role in the development and maintenance of the cerebral cortical barrier, which is the thin layer of tissue that lines the inside of the brain and helps to protect it from the surrounding environment.

In addition to its role in brain development, LAMB3 is also involved in the regulation of many other cellular processes that are important for overall cellular health and function. For example, it has been shown to be involved in the regulation of cell division, cell migration, and the transport of various cellular molecules across the cell membrane.

Despite its importance in many cellular processes, LAMB3 is not well understood, and there are few research studies that have focused on its role in these processes. This is why it is an attractive target for drug development, as researchers believe that targeting LAMB3 with small molecules or other compounds may be a way to develop new treatments for a variety of diseases.

One potential approach to targeting LAMB3 is to use small molecules that can modulate its activity. For example, researchers have shown that inhibitors of the protein kinase C (PKC), which is a enzyme that is involved in the regulation of many cellular processes, can be effective in blocking LAMB3's activity. This suggests that targeting PKC with small molecules may be a way to inhibit LAMB3's role in cellular processes that are important for brain development and function.

Another potential approach to targeting LAMB3 is to use antibodies that can selectively bind to the protein and then target it to specific cellular processes or structures within the cell. For example, researchers have shown that antibodies that recognize the extracellular domain of LAMB3 can be effective in blocking its activity in a variety of cellular processes, including cell division, cell migration, and the regulation of the cytoskeleton.

Once LAMB3 has been targeted with small molecules or antibodies, researchers will be able to study its role in various cellular processes and develop new treatments for a variety of diseases. This is an exciting area of research, as LAMB3's role in the regulation of cellular processes is still not fully understood, and there is much that can be learned about its function in the development and maintenance of brain health and function.

Protein Name: Lysosomal Associated Membrane Protein 3

Functions: Lysosomal membrane glycoprotein which plays a role in the unfolded protein response (UPR) that contributes to protein degradation and cell survival during proteasomal dysfunction (PubMed:25681212). Plays a role in the process of fusion of the lysosome with the autophagosome, thereby modulating the autophagic process (PubMed:24434718). Promotes hepatocellular lipogenesis through activation of the PI3K/Akt pathway (PubMed:29056532). May also play a role in dendritic cell function and in adaptive immunity (PubMed:9768752)

The "LAMP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LAMP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2 | LAMTOR3 | LAMTOR3P1 | LAMTOR4 | LAMTOR5 | LAMTOR5-AS1 | LanC-like proteins | LANCL1 | LANCL1-AS1 | LANCL2 | LANCL3 | LAP3 | LAP3P2 | LAPTM4A | LAPTM4B | LAPTM4BP2 | LAPTM5 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel) | LARGE-AS1 | LARGE1 | LARGE2 | LARP1 | LARP1B | LARP4 | LARP4B | LARP4P | LARP6 | LARP7 | LARS1 | LARS2 | LAS1L | LASP1 | LAT | LAT2 | LATS1 | LATS2 | LAX1 | LAYN | LBH | LBHD1 | LBP | LBR | LBX1 | LBX1-AS1 | LBX2 | LBX2-AS1 | LCA5 | LCA5L | LCAL1 | LCAT | LCDR | LCE1A | LCE1B | LCE1C | LCE1D | LCE1E | LCE1F | LCE2A | LCE2B | LCE2C | LCE2D | LCE3A | LCE3B | LCE3C | LCE3D | LCE3E | LCE4A | LCE5A | LCE6A | LCIIAR | LCK | LCLAT1 | LCMT1 | LCMT2 | LCN1 | LCN10 | LCN12 | LCN15 | LCN1P1 | LCN1P2 | LCN2 | LCN6 | LCN8 | LCN9 | LCNL1 | LCOR | LCORL | LCP1 | LCP2 | LCT | LCT-AS1 | LCTL | LDAF1 | LDAH | LDB1 | LDB2 | LDB3